CD5L and lung cancer: Based on these results, seven proteins, CD5L, CLEC3B, SERFINF1, ITIH4, SAA4, SERFINC1, and C20ORF3 (AMAP) were confirmed as being upregulated in EVs and were therefore considered as potential lung cancer biomarkers.